Pamine Forte (PharmaDerm a division of Fougera Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Pamine Forte drug offered from PharmaDerm a division of Fougera Pharmaceuticals Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | methscopolamine bromide |
SUBSTANCE NAME: | METHSCOPOLAMINE BROMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-03-25 |
END MARKETING DATE: | 0000-00-00 |
Pamine Forte HUMAN PRESCRIPTION DRUG Details:
Item Description | Pamine Forte from PharmaDerm a division of Fougera Pharmaceuticals Inc. |
LABELER NAME: | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2003-03-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10337-062_af011455-7a16-46eb-9823-42ca3abdbc98 |
PRODUCT NDC: | 10337-062 |
APPLICATION NUMBER: | NDA008848 |
Other METHSCOPOLAMINE BROMIDE Pharmaceutical Manufacturers / Labelers: